Celiac disease, irritable bowel syndrome, crohn’s disease and anaphylactic are all instigated by food allergies. Doctors order restrictive diets to help patients control inflammation and food reactions. While less well...
Megan Fix, MD, explained to current University of Utah medical residents how to recognize symptoms of burnout displayed by their peers and themselves, as well as how to access resources...
Temporal lobe epilepsy is a seizure disorder that may result from head trauma, childhood injuries, tumors, brain malformations, and infections. Karen Wilcox, PhD, Chair of Pharmacology and Toxicology at University...
Imagine how frustrating it would be if your smartphone could only communicate with people using the same cell carrier—and only using the apps that Apple or Samsung issued with the...
When a patient makes an appointment to see a provider, their choices are often dictated by outside influences: insurance networks, clinician availability, and referrals to a specialist. But when an...
2019 isn’t even halfway over and already this is the worst year for measles cases in 25 years. The Centers for Disease Control and Prevention says so far 704 people...
University of Utah Health researchers found that the median age at which 4-year-old children are first evaluated did not significantly decrease between 2010 to 2014. Increased efforts for early screening...
Enthusiastic university students from across the state and beyond spent the evening engaging with judges, volunteers, and fellow competitors at the Bench to Bedside competition.
Brenna Blackburn, Esther Chang, Qingqing Hu, Seungmin Kim, and Krista Ocier presented their posters at the Department of Family and Preventive Medicine Poster Summit.
The Annual Health Sciences LEAP Closing Dinner was held Friday, April 12th, 2019. This year's graduates are an exceptional group of students and we are proud to honor their achievements.
A team of researchers published the results of a phase 1 clinical trial for the drug Givosiran, which targets the liver cells ultimately responsible for acute hepatic porphyrias.
The annual #RUN2U event featured a patient panel sharing their experiences of living with rare and undiagnosed diseases with future health care providers.
An overwhelming majority of respondents from the NEJM Catalysts Insights Council, a qualified group of U.S. executives, clinical leaders, and clinicians agree that providing an exceptional patient experience is an...